A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides

Journal of Nutritional Biochemistry

Volumn 26, Issue 3, 2015, Pages 227-233

  Hartog, Anita ^a,b   Belle, Fabiën N ^a   Bastiaans, Jacqueline ^a,b   De Graaff, Priscilla ^a   Garssen, Johan ^a,b   Harthoorn, Lucien F ^a   Vos, Arjan P ^a,b  

^a Nutricia Nederland   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

CD103; IBD; Multifibre; Prebiotic; RALDH; Treg

Indexed keywords

CYTOKINE; DEXTRAN SULFATE; DOCUSATE SODIUM; INTERLEUKIN 10; POLYSACCHARIDE; BIOLOGICAL MARKER; PREBIOTIC AGENT; SERUM AMYLOID A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMPOSITION; COLITIS; CONTROLLED STUDY; DENDRITIC CELL; DIETARY INTAKE; ENTERIC FEEDING; ENTERITIS; HIGH FIBER DIET; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LAMINA PROPRIA; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; REMISSION; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C57BL MOUSE; COLON; DIET THERAPY; DISEASE MODEL; IMMUNOLOGY; INTESTINE MUCOSA; MESENTERIC LYMPHADENITIS; METABOLISM; MUCOSAL IMMUNITY; PATHOPHYSIOLOGY; RANDOMIZATION; SOLUBILITY; TH17 CELL;

MUS;

ANIMALS; BIOMARKERS; COLON; CYTOKINES; DENDRITIC CELLS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; IMMUNITY, MUCOSAL; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MESENTERIC LYMPHADENITIS; MICE, INBRED C57BL; PREBIOTICS; RANDOM ALLOCATION; SERUM AMYLOID A PROTEIN; SOLUBILITY; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84927689278     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.10.011     Document Type: Article

References (44)

1. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448(7152):427-434.
2. Orholm M., Munkholm P., Langholz E., Nielsen O.H., Sorensen T.I., Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991, 324(2):84-88.
3. Manichanh C., Borruel N., Casellas F., Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012, 9(10):599-608.
4. Subramanian S., Campbell B.J., Rhodes J.M. Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis 2006, 19(5):475-484.
5. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134(2):577-594.
6. Macia L., Thorburn A.N., Binge L.C., Marino E., Rogers K.E., Maslowski K.M., et al. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev 2012, 245(1):164-176.
7. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461(7268):1282-1286.
8. Ivanov I.I., Frutos Rde L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4(4):337-349.
9. Jaensson E., Uronen-Hansson H., Pabst O., Eksteen B., Tian J., Coombes J.L., et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008, 205(9):2139-2149.
10. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007, 204(8):1775-1785.
11. Manicassamy S., Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev 2011, 241(1):206-227.
12. Darrasse-Jeze G., Deroubaix S., Mouquet H., Victora G.D., Eisenreich T., Yao K.H., et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 2009, 206(9):1853-1862.
13. Dignass A., Van Assche G., Lindsay J.O., Lemann M., Soderholm J., Colombel J.F., et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis 2012, 4(1):28-62.
14. Danese S. New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 2012, 61(6):918-932.
15. Heuschkel R.B., Menache C.C., Megerian J.T., Baird A.E. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000, 31(1):8-15.
16. Day A.S., Burgess L. Exclusive enteral nutrition and induction of remission of active Crohn's disease in children. Expert Rev Clin Immunol 2013, 9(4):375-383. [quiz 384].
17. Grover Z., Muir R., Lewindon P. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease. J Gastroenterol 2013, 49(4):638-645.
18. Sann H., Erichsen J., Hessmann M., Pahl A., Hoffmeyer A. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice. Life Sci 2013, 92(12):708-718.
19. Vos A.P., Haarman M., van Ginkel J.W., Knol J., Garssen J., Stahl B., et al. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr Allergy Immunol 2007, 18(4):304-312.
20. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009, 15(8):1183-1189.
21. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104(34):13780-13785.
22. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55(2):205-211.
23. Machiels K., Joossens M., Sabino J., De Preter V., Arijs I., Eeckhaut V., et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014, 63(8):1275-1283.
24. Treem W.R., Ahsan N., Shoup M., Hyams J.S. Fecal short-chain fatty acids in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994, 18(2):159-164.
25. Harig J.M., Soergel K.H., Komorowski R.A., Wood C.M. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 1989, 320(1):23-28.
26. Kanauchi O., Suga T., Tochihara M., Hibi T., Naganuma M., Homma T., et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol 2002, 37(Suppl. 14):67-72.
27. Galvez J., Rodríguez-Cabezas M.E., Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res 2005, 49(6):601-608.
28. Tedelind S., Westberg F., Kjerrulf M., Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007, 13(20):2826-2832.
29. Meijer K., de Vos P., Priebe M.G. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health?. Curr Opin Clin Nutr Metab Care 2010, 13(6):715-721.
30. Luhrs H., Gerke T., Muller J.G., Melcher R., Schauber J., Boxberge F., et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002, 37(4):458-466.
31. Shevach E.M. Biological functions of regulatory T cells. Adv Immunol 2011, 112:137-176.
32. Boden E.K., Snapper S.B. Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol 2008, 24(6):733-741.
33. Chen J., Xie L., Toyama S., Hunig T., Takahara S., Li X.K., et al. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis. Int Immunopharmacol 2010, 11(5):610-617.
34. Eastaff-Leung N., Mabarrack N., Barbour A., Cummins A., Barry S. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 2010, 30(1):80-89.
35. Ishimaru N., Yamada A., Kohashi M., Arakaki R., Takahashi T., Izumi K., et al. Development of inflammatory bowel disease in Long-Evans Cinnamon rats based on CD4+CD25+Foxp3+regulatory T cell dysfunction. J Immunol 2008, 180(10):6997-7008.
36. Boehm F., Martin M., Kesselring R., Schiechl G., Geissler E.K., Schlitt H.J., et al. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. BMC Gastroenterol 2012, 12:97.
37. Geuking M.B., Cahenzli J., Lawson M.A., Ng D.C., Slack E., Hapfelmeier S., et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011, 34(5):794-806.
38. Zoumpopoulou G., Tsakalidou E., Dewulf J., Pot B., Grangette C. Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. Int J Food Microbiol 2009, 131(1):40-51.
39. Foligne B., Zoumpopoulou G., Dewulf J., Ben Younes A., Chareyre F., Sirard J.C., et al. A key role of dendritic cells in probiotic functionality. PLoS One 2007, 2(3):e313.
40. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G.M., et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005, 6(5):507-514.
41. Rescigno M. Dendritic cells in oral tolerance in the gut. Cell Microbiol 2011, 13(9):1312-1318.
42. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly Y.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341(6145):569-573.
43. Bremner A.R., Beattie R.M. Therapy of Crohn's disease in childhood. Expert Opin Pharmacother 2002, 3(7):809-825.
44. Fell J.M., Paintin M., Arnaud-Battandier F., Beattie R.M., Hollis A., Kitching P., et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000, 14(3):281-289.